Search - tctmd.com

Displaying 761 - 780 of 818

Sort: Relevancy | Date

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

News Conference News TCT 2012

Watchman LAA Effective in Patients Contraindicated for Warfarin

October 26, 2012

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

Presentation TCT 2012

Case 3: Optimal Transseptal Puncture for LAA Occlusion

Presenter: Brian Whisenant

October 24, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

ICE Guidance for LAA Closure: Advantages and Limitations

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

Cardia LAA Closure Device: Description and Preclinical Results

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

Presenter: A. Marc Gillinov

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Advertisement

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Watchman LAA Effective in Patients Contraindicated for Warfarin

Promising LAA Closure Devices and the Structural Heart Team Approach

Novel Devices Provide Options for LAA Therapy

Case 3: Optimal Transseptal Puncture for LAA Occlusion

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Lifetech LAA Closure Device: Description and Preclinical Results

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

ICE Guidance for LAA Closure: Advantages and Limitations

How to Become Trained and Start a LAA Closure Program

Cardia LAA Closure Device: Description and Preclinical Results

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content